🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of etavopi...
Status
Terminated
Location
University of Miami Hospital and Clinics
Start Date
2022-11-15
Trial ID
NCT05568225
Treatments Being Tested
This study is conducted to confirm whether etavopivat works well at reducin...
Status
Recruiting
Location
Uni of Alabama at Birmingham
Start Date
2025-02-17
Trial ID
NCT06612268
Treatments Being Tested
The study will test a new medicine, etavopivat, for sickle cell disease and...
Status
Recruiting
Location
All India Institute of Medical Sciences (AIIMS), Raipur
Start Date
2023-06-20
Trial ID
NCT05953584
Treatments Being Tested
This clinical trial is a Phase 2 study that will evaluate the safety and cl...
Status
Completed
Location
TOI Clinical Research
Start Date
2022-03-28
Trial ID
NCT04987489
Treatments Being Tested
An open-label, single arm study in patients 12 to 21 years of age with SCD ...
Status
Completed
Location
Emory University Children's Healthcare of Atlanta
Start Date
2024-03-09
Trial ID
NCT05725902
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics and safety of...
Status
Recruiting
Location
The Hospital for Sick Children
Start Date
2023-01-12
Trial ID
NCT06198712
Treatments Being Tested
Etavopivat is a new medicine under development for treating blood disorders...
Status
Recruiting
Location
Univ of Alabama Birmingham
Start Date
2025-01-10
Trial ID
NCT06609226
Treatments Being Tested
The study tests a new medicine called etavopivat in healthy Chinese partici...
Status
Completed
Location
Beijing Hospital
Start Date
2024-08-26
Trial ID
NCT06581627
Treatments Being Tested
FT-4202 is an oral small-molecule agonist of pyruvate kinase red blood cell...
Status
Completed
Location
Woodland International Research Group (SCD subjects only)
Start Date
2018-12-11
Trial ID
NCT03815695
Treatments Being Tested
Novo Nordisk is developing a new study medicine, Etavopivat, to treat indiv...
Status
Completed
Location
PAREXEL Intl - EPCU-Baltimore
Start Date
2025-06-09
Trial ID
NCT07023029
Treatments Being Tested